Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Prostate Cancer
PROSTATE CANCER ADVISOR
FEATURED CONTENT
-
-
Strategies for Managing Chronic Pain in Patients With Bone-Metastatic CRPC
An overview of prostate cancer metastases to bone is presented, including strategies for pain assessment and palliative radiotherapy. -
Prostate Cancer ADT Has Fewer Cardiovascular Risks Than Expected
Investigators found that men receiving androgen deprivation therapy for prostate cancer had a 1% rate of major adverse cardiovascular events. -
Controversy Prompts Another Update to NCCN Guidelines for Prostate Cancer
After physicians voiced concerns about an active surveillance recommendation, the NCCN panel revised the guidelines. -
Can Quality of Life Assessments Predict PFS, OS Across Cancer Types?
Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.
PROSTATE CANCER NEWS
New Model Improves Life Expectancy Estimates in Prostate Cancer Population
Trials Supporting Cancer Drug Approvals Lack Information on Gender
Proton Beam Therapy Increasingly Used to Treat Cancers, Even When Evidence of Effectiveness Is Lacking
Orteronel Does Not Improve Overall Survival in Prostate Cancer
BRCA1/2 Variants Associated With More Cancers Than Previously Thought
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Prostate Cancer
Loading... 
Loading...